Recursion has rapidly established itself as a leader in the field of AI-enabled biotechnology. The company's BioHive-2 ...

Dr. Doberstein joins a distinguished group of board members with deep expertise in biotechnology, AI-driven drug discovery, and clinical development, further strengthening Invea’s leadership as it ...

Biomedicines, a Flagship Pioneering company leading in AI-enabled protein therapeutics discovery and development ...

November 2024 has seen a variety of biotech deals take place to advance therapies across different stages in development.

Biomedicines as part of its efforts to drive growth and innovation in the biopharmaceutical sector. Established in 2021 and ...

Technologies should be designed to serve the greater good, promoting fairness, transparency, and positive impact for the ...

Introduction: Recent advances in machine learning provide ... in developing predictive medicine algorithms, so there is definitely an emerging need for effective processing methodology. We believe ...

Former CEO of NPS Pharma brings strong biotech expertise to further accelerate GEn1E’s development and commercialization of ...

One of the most common blood tests in the world, CBC tests are run billions of times each year, can be imprecise. Experts are ...

She completed a residency in internal medicine and a ... along with insights from machine learning and AI, Cartography is identifying and developing therapeutics against highly specific targets and ...

Machine learning tools can increase the pace of biology research and open the door to new research questions, but the ...